{"database": "lobbying", "table": "lobbying_activities", "is_view": false, "human_description_en": "where filing_uuid = \"a4863211-ec4e-4e0d-b10b-4df67d004ad2\", filing_year = 2015 and issue_code = \"HCR\" sorted by filing_year descending", "rows": [[1683451, "a4863211-ec4e-4e0d-b10b-4df67d004ad2", "Q1", "BIOTECHNOLOGY INNOVATION ORGANIZATION", 6245, "BIOTECHNOLOGY INNOVATION ORGANIZATION", 2015, "first_quarter", "HCR", "Biosimilars\n     -Biosimilar User Fee Act Implementation\n     -Colombia Biologics Regulations\n     -Implementation of Affordable Care Act\n     -Interchangeability and Pharmacy Substitution\n     -Mexico Biologics Regulations\n     -Naming\n     -Patent Certification\n\nFunding for National Institutes of Health\n     -S 320: Medical Innovation Act of 2015  \n     -Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016\n\nFunding for Centers for Disease Control and Prevention Vaccine Programs \n     -Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016\n\nVaccine Access/Financing\n     -Adult Immunization (Senate Discussion Draft)\n     -S.2694: Ensuring Access to Primary Care for Women and Children Act\n      \n340B Drug Pricing Program\n     -Implementation of Affordable Care Act\n     -Program Implementation & Oversight\n     -Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016\n\nFunding for FDA\n     -Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016\n     -S 320: Medical Innovation Act of 2015  \n\nIndependent Payment Advisory Board\n     \nFunding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement \n     -Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016\n\nBiodefense Research, Development, and Procurement Issues (Non-funding)\n     \nTransPacific Partnership  \n     -Data and Intellectual Property Protection for Pharmaceuticals\n     -Regulatory Transparency\n\nTransatlantic Trade and Investment Partnership  \n     -Intellectual Property Issues\n     -Regulatory Harmonization \n     -Reimbursement Transparency\n\nReimbursement for Innovative Products\n     -Medicare Part D Prescription Drug Program\n     -Medicare Part B Physician-Administered Products\n     \nSequestration of PDUFA Fees\n     --H.R. 1078: FDA Safety over Sequestration Act  \n \nDrug Evaluation and Review\n     -Compassionate Use/Expanded Access\n     -Implementation of the FDA Safety and Innovation Act\n\nOrphan Drug Act Tax Credit \n     \nMedicare Physician Payment Sustainable Growth Rate Formula \n- HR 2: Medicare Access and CHIP Reauthorization Act of 2015\n\n21st Century Cures Initiative\n     -Biomarkers and Regulatory Science Improvements\n     -Communication with Healthcare Professionals\n     -Expanded Access to Investigational Drugs\n     -Expedited Pathways\n     -FDA Hiring Flexibility\n     -FDA Management and Financial Accountability\n     -Innovation Incentives\n     -Longitudinal Study of Chronic Diseases\n     -Patient Access to Approved Drugs\n     -Patient-Focused Drug Development  \n     -Use of Real-World Evidence \n     -Vaccine and Anti-Microbial Resistance Product Development and Incentives\n     -ADAPT Act (House Discussion Draft)\n     -Sunshine Act Amendments \n     -Coding \n     -Coverage with Evidence Development \n    \nFunding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative\n-Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016\n\nSenate Budget Resolution S. Con. Res. 11\n     - Amendment on Medicare non-interference provision\n     - Amendment on compounded drugs across state lines\n\nVaccines and Infectious Diseases - General\n     \nColombia National Development Plan \n     -Regulatory Issues\n     -Reimbursement Issues\n     -Intellectual Property Issues", "Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Patent & Trademark Office (PTO),Securities & Exchange Commission (SEC),SENATE,Treasury, Dept of,U.S. Trade Representative (USTR),White House Office", null, 2010000, 0, 0, "2015-04-20T17:59:01.790000-04:00"]], "truncated": false, "filtered_table_rows_count": 1, "expanded_columns": [], "expandable_columns": [[{"column": "filing_uuid", "other_table": "lobbying_filings_raw", "other_column": "filing_uuid"}, "registrant_name"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, filing_uuid, filing_type, registrant_name, registrant_id, client_name, filing_year, filing_period, issue_code, specific_issues, government_entities, income_amount, expense_amount, is_no_activity, is_termination, received_date from lobbying_activities where \"filing_uuid\" = :p0 and \"filing_year\" = :p1 and \"issue_code\" = :p2 order by filing_year desc limit 101", "params": {"p0": "a4863211-ec4e-4e0d-b10b-4df67d004ad2", "p1": "2015", "p2": "HCR"}}, "facet_results": {"issue_code": {"name": "issue_code", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_uuid=a4863211-ec4e-4e0d-b10b-4df67d004ad2&filing_year=2015&issue_code=HCR", "results": [{"value": "HCR", "label": "HCR", "count": 1, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=a4863211-ec4e-4e0d-b10b-4df67d004ad2&filing_year=2015", "selected": true}], "truncated": false}, "filing_year": {"name": "filing_year", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_uuid=a4863211-ec4e-4e0d-b10b-4df67d004ad2&filing_year=2015&issue_code=HCR", "results": [{"value": 2015, "label": 2015, "count": 1, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=a4863211-ec4e-4e0d-b10b-4df67d004ad2&issue_code=HCR", "selected": true}], "truncated": false}, "filing_period": {"name": "filing_period", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_uuid=a4863211-ec4e-4e0d-b10b-4df67d004ad2&filing_year=2015&issue_code=HCR", "results": [{"value": "first_quarter", "label": "first_quarter", "count": 1, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=a4863211-ec4e-4e0d-b10b-4df67d004ad2&filing_year=2015&issue_code=HCR&filing_period=first_quarter", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "received_date", "type": "date", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=a4863211-ec4e-4e0d-b10b-4df67d004ad2&filing_year=2015&issue_code=HCR&_facet_date=received_date"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 1337.9151350818574, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}